Tag Archives: TMUS

Best Medical Stocks To Buy Right Now

Icon Plc (NASDAQ:ICLR) – Stock analysts at KeyCorp issued their Q1 2019 EPS estimates for shares of Icon in a report issued on Monday, September 10th. KeyCorp analyst D. Hooker expects that the medical research company will post earnings of $1.66 per share for the quarter. KeyCorp currently has a “Overweight” rating and a $157.00 target price on the stock. KeyCorp also issued estimates for Icon’s Q2 2019 earnings at $1.72 EPS, Q3 2019 earnings at $1.78 EPS and Q4 2019 earnings at $1.84 EPS.

Get Icon alerts:

Other equities research analysts also recently issued research reports about the company. Jefferies Financial Group lifted their target price on Icon to $150.00 and gave the stock a “buy” rating in a report on Friday, June 1st. BidaskClub upgraded Icon from a “hold” rating to a “buy” rating in a research report on Wednesday, May 23rd. Robert W. Baird restated a “buy” rating and issued a $154.00 price objective on shares of Icon in a research report on Thursday, July 26th. SunTrust Banks boosted their price objective on Icon to $153.00 and gave the company a “buy” rating in a research report on Thursday, July 26th. Finally, Zacks Investment Research upgraded Icon from a “hold” rating to a “buy” rating and set a $147.00 price objective for the company in a research report on Thursday, July 5th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $146.22.

Best Medical Stocks To Buy Right Now: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Brink’s (NYSE:BCO) Q4 2018 Earnings Conference CallFeb. 6, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Sean Williams]

    Even though marijuana is on its way to becoming legal in Canada and it’s been given the thumbs-up for medical purposes in 30 U.S. states, this is still very much a cash business. Federal scheduling in the U.S. ensures that access to lines of credit, loans, and even a basic checking account are few and far between. Meanwhile, in Canada, only recently have banks been given the OK to work strategically with marijuana businesses. This opens the door for armored truck and ATM service companies like Brink’s Company (NYSE:BCO) to succeed.

  • [By Joseph Griffin]

    BridgeCoin (CURRENCY:BCO) traded 7.5% lower against the US dollar during the one day period ending at 17:00 PM Eastern on June 15th. One BridgeCoin coin can currently be bought for $1.24 or 0.00019057 BTC on major exchanges. In the last week, BridgeCoin has traded down 33.1% against the US dollar. BridgeCoin has a market cap of $33.52 million and approximately $15,787.00 worth of BridgeCoin was traded on exchanges in the last day.

  • [By Max Byerly]

    Shares of Brink’s (NYSE:BCO) have earned a consensus rating of “Buy” from the nine research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $99.50.

  • [By Dan Caplinger]

    Thursday was a largely down day for the stock market, with the Dow Jones Industrial Average taking the biggest hit of the major benchmarks. The global turmoil over trade got a lot closer to home as the U.S. imposed new restrictions that led the Canadian government to issue retaliatory tariffs in response. Yet many broader-based measures of the market fell only slightly, showing that much of what drives the economy isn’t as dependent on trade as traditional industrial giants. Good news also sent some key stocks higher. Madrigal Pharmaceuticals (NASDAQ:MDGL), Brink’s (NYSE:BCO), and Applied Optoelectronics (NASDAQ:AAOI) were among the best performers on the day. Here’s why they did so well.

Best Medical Stocks To Buy Right Now: Noble Energy Inc.(NBL)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Noble Midstream (NYSE:NBLX) has a bold plan to grow its already impressive 7.4%-yielding distribution to investors by 20% per year all the way through 2022, which is one of the fastest rates in the midstream sector. Driving that growth would be the expansion of the company’s oil and gas gathering system to support the anticipated increase in production from customers like its parent, Noble Energy (NYSE:NBL).

  • [By Matthew DiLallo]

    Fueling that forecast is the company’s ability to expand its midstream footprint to support the growth of its customers, including its parent Noble Energy (NYSE:NBL). The company operates several gathering systems in both the Permian Basin and DJ Basin that it expects to continue expanding as customers drill more wells.

  • [By Dan Caplinger]

    Yet along with those gains has come continued volatility, and even among the biggest companies in the market, some have faced substantial setbacks that have caused their shares to fall 15% or more in August. As of today, Hanesbrands (NYSE:HBI), Dentsply Sirona (NASDAQ:XRAY), and Noble Energy (NYSE:NBL) have been the worst-performing members of the S&P 500 so far this month, and below, you’ll learn more about how they got there and what’s ahead for their respective businesses.

Best Medical Stocks To Buy Right Now: Materialise NV(MTLS)

Advisors’ Opinion:

  • [By Logan Wallace]

    TheStreet upgraded shares of Materialise (NASDAQ:MTLS) from a c+ rating to a b- rating in a research report report published on Thursday.

    Several other brokerages have also commented on MTLS. BidaskClub upgraded shares of Materialise from a sell rating to a hold rating in a report on Tuesday, August 28th. ValuEngine upgraded shares of Materialise from a hold rating to a buy rating in a report on Friday, August 24th. Finally, Zacks Investment Research lowered shares of Materialise from a hold rating to a strong sell rating in a report on Thursday, August 9th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company presently has an average rating of Hold and an average target price of $19.00.

  • [By Joseph Griffin]

    Blackline (NASDAQ: MTLS) and Materialise (NASDAQ:MTLS) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Materialise (MTLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Materialise (NASDAQ:MTLS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Navigator (NYSE:NVGS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Stephan Byrd]

    Materialise (NASDAQ:MTLS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Royal Caribbean Cruises (NYSE:RCL) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Materialise (MTLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Buy Right Now: First Busey Corporation(BUSE)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of First Busey Co. (NASDAQ:BUSE) hit a new 52-week high and low during trading on Monday . The company traded as low as $33.22 and last traded at $32.70, with a volume of 1006 shares traded. The stock had previously closed at $33.00.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on First Busey (BUSE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp bought a new stake in shares of First Busey Co. (NASDAQ:BUSE) during the 1st quarter, Holdings Channel reports. The firm bought 7,000 shares of the bank’s stock, valued at approximately $208,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on First Busey (BUSE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Buy Right Now: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In other news, after a week, shares of T-Mobile (NASDAQ:TMUS) and Sprint (NYSE:S) are lower than they were before they announced a merger deal. The Fools discuss the likelihood of the plan making it past regulators and shareholders to closing, and consider whether it would be a win or a loss for customers.

  • [By ]

    Of course T-Mobile (TMUS) and Sprint (S) have reportedly restarted merger talks, joining forces to take on Verizon (VZ) and AT&T (T) makes perfect sense.

  • [By Adam Levy]

    T-Mobile (NASDAQ:TMUS) has been looking to get into video distribution since its Layer3 TV acquisition in December 2017. The company initially planned to launch a pay-TV service by the end of 2018, but it’s pushed back those plans to the first half of 2019.

  • [By ]

    After years of on-again, off-again talks, Sprint (S) and T-Mobile (TMUS)  finally announced a merger Sunday.

    Sprint investors will receive 0.10256 shares of T-Mobile for each share of Sprint. Based on T-Mobile’s close at $64.52 on Friday, the deal values Sprint at $6.62 per share. Including assumed debt, the deal values Sprint at about $59 billion.

Top Performing Stocks To Own For 2019

CHAPEL HILL, N.C. (MarketWatch) — “The last shall be first” is not only a powerful nugget of theological wisdom; it’s also good investment advice.

Consider the worst-performing stock in the 30-member Dow Jones Industrial Average
DJIA, -0.29%
in 2015: Wal-Mart
WMT, -0.20%
The retailer’s shares produced a dividend-adjusted loss of 26.6% in 2015, but, with two trading days left for the year, is up 16.4% in 2016, handily beating the broader market.

Top Performing Stocks To Own For 2019: Intuitive Surgical Inc.(ISRG)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In the healthcare world, one of those has to be the impressive quarterly report from Intuitive Surgical (NASDAQ:ISRG). The company increased its revenue by 25%, and accelerated its sales of the da Vinci robotic surgical systems that made it famous. But it’s not just the expensive hardware that is allowing it to prosper — it’s that every machine needs a steady supply of the disposable instruments and accessories used during its procedures. The Fools consider the recent numbers, the outlook, and the investment thesis for Intuitive Surgical stock. But in the, say, anti-healthcare space, cigarette slinger Philip Morris International (NYSE:PM) took a big hit as demand slackened in major foreign markets. Sales of its e-cig devices are also not growing the way management had hoped.

  • [By Brian Stoffel]

    Investors in Intuitive Surgical (NASDAQ:ISRG) know the script by now. The company forecasts solid — but not heady — procedure growth. When the end of the quarter comes, not only does it exceed expectations, but it also sells significantly more daVinci systems than it did the year before.

  • [By Motley Fool Transcribing]

    Intuitive Surgical (NASDAQ:ISRG) Q4 2018 Earnings Conference CallJan. 24, 2019 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Performing Stocks To Own For 2019: The Swatch Group AG (SWGAY)

Advisors’ Opinion:

  • [By Logan Wallace]

    EAGLE POINT Cr/COM (OTCMKTS: SWGAY) and SWATCH Grp AG/ADR (OTCMKTS:SWGAY) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

  • [By Ethan Ryder]

    SWATCH Grp AG/ADR (OTCMKTS:SWGAY) was downgraded by analysts at UBS Group from a “buy” rating to a “hold” rating in a research note issued on Friday, The Fly reports.

Top Performing Stocks To Own For 2019: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Joe Tenebruso]

    With T-Mobile’s (NASDAQ:TMUS) shares down 15% over the past 12 months, the market is presenting investors with an entry point. That’s because there are a number of catalysts that could help the wireless carrier rebound to new highs in the coming year. Specifically, here are three reasons why you may want to consider buying T-Mobile stock today.

  • [By Adam Levy]

    Verizon saw service revenue tank after T-Mobile (NASDAQ:TMUS) started its Un-carrier initiatives, including unbundling installment plans and service contracts and bringing back unlimited data plans. The moves, combined with Sprint’s (NYSE:S) aggressive pricing, put pressure on the larger competitor to follow suit and make some customer-friendly changes in order to prevent subscriber losses. Those measures coupled with limited subscriber growth led to a decline in wireless service revenue.

  • [By Jamal Carnette, CFA]

    Perhaps the biggest news to come out of the wireless industry since the smartphone is the proposed T-Mobile (NASDAQ:TMUS) and Sprint (NYSE:S) merger. According to The Wall Street Journal, T-Mobile is paying $26 billion for the Kansas-based provider if shareholders and regulators allow it.

  • [By Trey Thoelcke]

    T-Mobile US Inc. (NASDAQ: TMUS) also saw a mid-month golden cross, which was its second one this year. The company recently admitted that up to 3 million of its customers were affected by a data breach. Yet its shares are up more than 8% year to date, on last look. Here too analysts recommend holding the shares.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on T-Mobile Us (TMUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Dan Caplinger]

    Shares of Sprint climbed 17% in the wake of news that the telecom company might once again be in talks to get an acquisition bid from rival wireless carrier T-Mobile US (NASDAQ:TMUS). The on-again, off-again deal has been in the works for years without having made progress, but the realities of needing to address the huge costs of upgrading to new 5G network standards poses a substantial competitive obstacle that could make a combination more rewarding. Antitrust concerns will remain intact, especially given that a Sprint/T-Mobile merger would reduce the number of major carriers in the U.S. market to just three. Nevertheless, hope springs eternal, and investors seem to have at least some confidence that a deal might get done.

Top Performing Stocks To Own For 2019: United Parcel Service Inc.(UPS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Before the markets open, Bristol-Myers Squibb Company (NYSE: BMY) is projected to report quarterly earnings at $0.85 per share on revenue of $5.24 billion. Bristol-Myers shares rose 0.95 percent to $52.25 in after-hours trading.
    AT&T Inc. (NYSE: T) reported weaker-than-expected earnings

  • [By Adam Levy]

    Amazon is working to reduce shipping expenses by moving more of its logistics and deliveries in-house with Amazon Air and a homegrown network of delivery service providers. On the company’s fourth-quarter earnings call, CFO Brian Olsavsky provided some additional details about how Amazon manages its shipments between its own network and partners including FedEx (NYSE:FDX) and UPS (NYSE:UPS).

  • [By Paul Ausick]

    Not included in the count are 100,000 jobs that United Parcel Service Inc. (NYSE: UPS), Chief Strategy and Transformation Officer Scott Price told The Street his company plans to add this year. Neither UPS nor Amazon has officially announced 2018 holiday hiring plans, but assuming that Amazon plans to hire at least as many as it hired last year, the total could quickly rise to 560,000.

Top 5 Blue Chip Stocks To Own Right Now

Sports and stocks go hand in hand.

Wall Street denizens often talk about slam dunk investments and describe the economic cycle as being in a particular inning.

So it makes perfect sense that there’s an ETF dedicated to the business of sports.

The ProSports Sponsors exchange-traded fund, which has the ticker symbol FANZ (FANZ), invests in companies that have business deals with the four major US team sports leagues.

Nick Fullerton, CEO of SportsETFs, the company behind the fund, said it was set up last year to take advantage of the popularity of team sports, which bring in big dollars.

Legal gambling, which is set to spread across the United States, could boost that popularity even more.

Fullerton was quick to point out that the companies in the FANZ ETF must have an actual sponsorship with a major league, and not just a naming rights deal on a stadium.

No CMGIs or Enrons here.

“These are blue chip companies with strong balance sheets and cash flow,” Fullerton said.

Top 5 Blue Chip Stocks To Own Right Now: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Vermillion (NASDAQ: VRML) and Myriad Genetics (NASDAQ:MYGN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

  • [By Logan Wallace]

    Vermillion, Inc. (NASDAQ:VRML) CFO Robert Harry Beechey bought 100,000 shares of Vermillion stock in a transaction dated Tuesday, August 14th. The stock was acquired at an average cost of $0.52 per share, for a total transaction of $52,000.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

  • [By Benzinga News Desk]

    Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link

    ECONOMIC DATA
    US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M
    Existing home sales report for April will be released at 10:00 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET.
    Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET.
    The Treasury is set to auction 7-year notes at 1:00 p.m. ET.
    The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET.
    Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET.
    Data on money supply for the latest week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    UBS upgrades Deere (NYSE: DE) from Neutral to Buy
    Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform
    Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold
    Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Max Byerly]

    Vermillion, Inc. (NASDAQ:VRML) CFO Robert Harry Beechey acquired 75,000 shares of the company’s stock in a transaction that occurred on Thursday, August 23rd. The shares were acquired at an average cost of $0.61 per share, for a total transaction of $45,750.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Stephan Byrd]

    Media headlines about Vermillion (NASDAQ:VRML) have been trending somewhat positive this week, Accern reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Vermillion earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.6924212135165 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 5 Blue Chip Stocks To Own Right Now: BWX Technologies, Inc.(BWXT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BWX Technologies (BWXT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BWX Technologies (BWXT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    News coverage about BWX Technologies (NYSE:BWXT) has trended somewhat positive on Friday, Accern reports. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. BWX Technologies earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 44.8987761555585 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Stephan Byrd]

    Synovus Financial Corp acquired a new stake in shares of BWX Technologies (NYSE:BWXT) during the first quarter, Holdings Channel reports. The fund acquired 1,892 shares of the technology company’s stock, valued at approximately $122,000.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BWX Technologies (BWXT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Blue Chip Stocks To Own Right Now: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Chris Hill]

    Next up, the Justice Department has formally charged Huawei with a list of crimes that include stealing trade secrets from T-Mobile (NASDAQ:TMUS) as well as bank and wire fraud. And while China will have the telecom and smartphone giant’s back, there’s probably no way this ends well. Finally, after last week’s Brumadinho dam disaster, which spilled 3 million gallons of contaminated mining waste, destroyed a town, and killed at least 65 people in Brazil, Vale (NYSE:VALE) shareholders have to be asking themselves if the company is doomed.

  • [By Daniel B. Kline]

    Give Sprint (NYSE:S) CEO Marcelo Claure credit for stopping the bleeding. His efforts have at least stopped his company’s steady decline in a highly competitive battle with low-price rival T-Mobile (NASDAQ:TMUS), as well as bigger players Verizon (NYSE:VZ) and AT&T (NYSE:T).

  • [By ]

    After years of on-again, off-again talks, Sprint (S) and T-Mobile (TMUS)  finally announced a merger Sunday.

    Sprint investors will receive 0.10256 shares of T-Mobile for each share of Sprint. Based on T-Mobile’s close at $64.52 on Friday, the deal values Sprint at $6.62 per share. Including assumed debt, the deal values Sprint at about $59 billion.

Top 5 Blue Chip Stocks To Own Right Now: Taiwan Semiconductor Manufacturing Company Ltd.(TSM)

Advisors’ Opinion:

  • [By Anders Bylund]

    Cryptocurrency mining is no longer the leading theme in AMD’s analyst reports. Instead, Wall Street’s finest are focusing on AMD’s solid Ryzen and EPYC brands taking market share from Intel (NASDAQ:INTC) in both the server systems and gaming rig markets. On top of AMD’s sharp execution in recent quarters, Intel appears to have fumbled the manufacturing technology lead to the point where AMD can lean on foundry partner Taiwan Semiconductor Manufacturing (NYSE:TSM) to deliver seven-nanometer chip architectures while Intel’s in-house manufacturing lines are stuck at 10 nm.

  • [By Anders Bylund, Chris Neiger, and Ashraf Eassa]

    We asked a handful of your fellow tech investors here at The Motley Fool what they see as the best tech investments in early May. Read on to see why our panelists recommend Taiwan Semiconductor Manufacturing (NYSE:TSM), PayPal (NASDAQ:PYPL), and Crown Castle International (NYSE:CCI) at this moment in time.

  • [By Ashraf Eassa]

    Contract chip manufacturing giant Taiwan Semiconductor Manufacturing Company (NYSE:TSM) recently announced that for 2018, it expects to boost its capital expenditure budget to between $11.5 billion and $12 billion, up from a prior range of $10.5 billion to $11 billion. 

  • [By ]

    The capex budget – In January, Intel set a 2018 capital spending budget of $13.5 billion to $14.5 billion, which was easily above 2017 capex of $11.8 billion. Will the budget be tweaked? Last week, Taiwan Semiconductor (TSM) , the world’s biggest chip foundry, upped its 2018 capex budget by $1 billion to a range of $11.5 billion to $12 billion.

  • [By Ashraf Eassa]

    But there are companies similar to Intel — that is, large-cap chip companies that dominate in their respective fields — that I think are worth considering more closely: Broadcom (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company (NYSE:TSM), and Micron (NASDAQ:MU).

  • [By Ashraf Eassa]

    Taiwan Semiconductor Manufacturing Company (NYSE:TSM), or TSMC for short, is one of Apple’s (NASDAQ:AAPL) most important suppliers. The company has manufactured Apple’s A-series chips starting with the A8 and continuing through to today’s A12 Bionic chip and has been the exclusive manufacturer of all but one of those chips — the A9.

Top 5 Blue Chip Stocks To Own Right Now: Prothena Corporation plc(PRTA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Prothena Corporation plc (NASDAQ: PRTA) shares dropped 69 percent to $11.43 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Unfortunately, there were no statistically significant difference between the two treatment groups.

  • [By Chris Lange]

    Prothena Corp. PLC (NASDAQ: PRTA) shares hit a multiyear low on Monday, one not seen since 2013. This came on the heels of news that the company would be discontinuing development of NEOD001, an investigational antibody that was being evaluated for the treatment of AL amyloidosis.

  • [By Brian Feroldi]

    In response to announcing that it is stopping all clinical development of its lead product candidate, Prothena (NASDAQ:PRTA), a clinical-stage biotech focused on neuroscience and orphan diseases, saw its shares fall 69% as of 11 a.m. EDT.

  • [By Jon C. Ogg]

    Creating a treatment for a rare disease or rare disorder can come with massive upside if the treatment is successful. That said, the risk is that a company can implode if its rare disease treatment fails in a drug study. Now it looks as if Prothena Corporation plc (NASDAQ: PRTA) is on the verge of implosion based upon how its stock price reacted.

  • [By Lisa Levin]

    Prothena Corporation plc (NASDAQ: PRTA) shares dropped 68 percent to $11.79 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Unfortunately, there were no statistically significant difference between the two treatment groups.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 10 Low Price Stocks To Buy For 2019

A few weeks ago, we published an article that characterized Gilead (GILD) as a “Value Trap.” That article was a follow-up to an earlier article which used our work on Gilead as an example of how a solid conceptual framework could help investors make better decisions. Both of these articles were based on a 16-page valuation report on Gilead we published to our members in September, 2016.

We caught a lot of flack for the recent characterization of Gilead as a value trap, but our opinion was redeemed on February 7th, when the stock fell heavily after a disappointing earnings announcement.

In today’s article, we’ll take another look at the valuation process – the most important weapon in an investor’s arsenal – in a continuation of the Gilead example. We would invite new readers to read through each of the earlier articles as well, to get a picture of the overall process!

Investing Anecdotes are Dangerous!

What interested us in September 2016, when we made our original analysis of Gilead, was the noise among the value investing community about what a deal Gilead was because the stock was trading at such a low Price-to-Earnings (P/E) ratio (See our article Three Things You Should Know About Gilead).

Top 10 Low Price Stocks To Buy For 2019: USG Corporation(USG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    USG Co. (NYSE:USG) – Equities research analysts at SunTrust Banks reduced their Q3 2018 earnings per share estimates for shares of USG in a report issued on Monday, July 9th. SunTrust Banks analyst K. Hughes now forecasts that the construction company will post earnings of $0.57 per share for the quarter, down from their previous estimate of $0.61. SunTrust Banks currently has a “Hold” rating and a $44.00 price target on the stock. SunTrust Banks also issued estimates for USG’s FY2018 earnings at $2.05 EPS, Q3 2019 earnings at $0.71 EPS and FY2019 earnings at $2.53 EPS.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

    A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Jordan Wathen]

    As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG’s board members who are up for re-election at this year’s annual meeting, a clear message that Buffett is ready to cash in, even if USG’s management and board are not.

  • [By Dan Caplinger]

    Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett’s involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

Top 10 Low Price Stocks To Buy For 2019: Tekla Healthcare Opportunies Fund(THQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Tekla Healthcare Opportunities Fund (NYSE:THQ) declared a monthly dividend on Monday, June 11th, Wall Street Journal reports. Investors of record on Wednesday, June 20th will be paid a dividend of 0.1125 per share on Friday, June 29th. This represents a $1.35 dividend on an annualized basis and a dividend yield of 7.72%. The ex-dividend date of this dividend is Tuesday, June 19th.

Top 10 Low Price Stocks To Buy For 2019: Ampco-Pittsburgh Corporation(AP)

Advisors’ Opinion:

  • [By ]

    New York (AP) — Four more deaths have been linked to a national food poisoning outbreak blamed on tainted lettuce, bringing the total to five.

    Health officials have tied the E. coli outbreak to romaine lettuce grown in Yuma, Arizona. The growing season there ended six weeks ago, and it's unlikely any tainted lettuce is still in stores or people's homes, given its short shelf life. But there can be a lag in reporting, and reports of illnesses have continued to come in.

  • [By ]

    Cayce, S.C. (AP) — A crash between an Amtrak passenger train and a CSX freight train in South Carolina has left at least two people dead and more than 50 injured

  • [By ]

    Wellington, New Zealand (AP) — New Zealand plans to slaughter about 150,000 cows as it tries to eradicate a strain of disease-causing bacteria from the national herd.

  • [By Shane Hupp]

    Deutsche Bank AG boosted its holdings in Ampco-Pittsburgh Corp (NYSE:AP) by 117.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 19,599 shares of the industrial products company’s stock after purchasing an additional 10,578 shares during the quarter. Deutsche Bank AG’s holdings in Ampco-Pittsburgh were worth $242,000 at the end of the most recent quarter.

  • [By ]

    Phoenix (AP) — The classified advertising site Backpage.com ignored warnings to stop running advertisements promoting prostitution, sometimes involving children, because the lucrative enterprise brought in half a billion dollars, according to an indictment unsealed Monday.

Top 10 Low Price Stocks To Buy For 2019: BGC Partners, Inc.(BGCP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BGC Partners (BGCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    DEUTSCHE BOERSE/ADR (OTCMKTS: DBOEY) and BGC Partners (NASDAQ:BGCP) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

  • [By ]

    BGC Partners (BGCP) : “We’re in a market where Goldman Sachs (GS) got slammed. I’m going with them.”

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Logan Wallace]

    LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

  • [By Ethan Ryder]

    UBS Group AG raised its holdings in shares of BGC Partners, Inc. (NASDAQ:BGCP) by 248.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,519,131 shares of the financial services provider’s stock after purchasing an additional 1,082,829 shares during the quarter. UBS Group AG’s holdings in BGC Partners were worth $20,432,000 as of its most recent SEC filing.

Top 10 Low Price Stocks To Buy For 2019: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.

Top 10 Low Price Stocks To Buy For 2019: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Brian Orelli]

    On Friday evening, bluebird bio (NASDAQ:BLUE) and Celgene (NASDAQ:CELG) will kick things off with their BCMA-targeted CAR T, bb2121, for patients with multiple myeloma who have failed other treatments. The results from the phase I trial have been impressive so far, albeit in a limited number of patients. The new data should include the expansion cohort of patient treated at the dose to be used in later-stage trials.

  • [By Stephan Byrd]

    bluebird bio (NASDAQ:BLUE) was up 0% during mid-day trading on Thursday . The stock traded as high as $190.50 and last traded at $189.30. Approximately 892,250 shares traded hands during mid-day trading, an increase of 14% from the average daily volume of 779,838 shares. The stock had previously closed at $189.30.

  • [By Ethan Ryder]

    Blue Protocol (CURRENCY:BLUE) traded 5.2% lower against the US dollar during the one day period ending at 18:00 PM ET on June 27th. In the last seven days, Blue Protocol has traded down 29.4% against the US dollar. Blue Protocol has a total market capitalization of $3.16 million and approximately $3,034.00 worth of Blue Protocol was traded on exchanges in the last 24 hours. One Blue Protocol token can currently be bought for approximately $0.0862 or 0.00001406 BTC on exchanges including IDEX, YoBit, CoinExchange and EtherDelta (ForkDelta).

  • [By Motley Fool Staff]

    In his fourth segment — something blue — he talks about clinical-stage gene-therapy company bluebird bio(NASDAQ:BLUE). It’s a RuleBreakers recommendation, and it has been for almost three and a half years. It’s also a fine illustration of some key Foolish principles of investing.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Brian Orelli]

    bluebird bio (NASDAQ:BLUE) reportedfirst-quarter earnings last week, but like the biotech typically does, management didn’t hold a conference call, which makes the earnings release more of a rehash of the quarter than an actual update.

Top 10 Low Price Stocks To Buy For 2019: Cabot Corporation(CBT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Scopus Asset Management L.P. lifted its position in shares of Cabot Corp (NYSE:CBT) by 74.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 435,000 shares of the specialty chemicals company’s stock after buying an additional 185,000 shares during the quarter. Scopus Asset Management L.P.’s holdings in Cabot were worth $24,238,000 at the end of the most recent quarter.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Joseph Griffin]

    Sei Investments Co. increased its position in shares of Cabot Corp (NYSE:CBT) by 137.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,527 shares of the specialty chemicals company’s stock after acquiring an additional 40,219 shares during the quarter. Sei Investments Co. owned approximately 0.11% of Cabot worth $3,874,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Low Price Stocks To Buy For 2019: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Adam Levy]

    AT&T hopes its bundle can differentiate its product from competitors like Verizon (NYSE:VZ) and T-Mobile (NASDAQ:TMUS), and improve its customer retention. But as it adds more options to the bundle, it could deteriorate its margins without providing meaningful value to many customers.

  • [By ]

    Over on Real Money, Cramer talks about how to trade the highly unlikely deal between Sprint (S) and T-Mobile (TMUS) . Get more of his insights with a free trial subscription to Real Money.

  • [By Paul Ausick]

    The margins for wireless carriers have frayed as Sprint Corp. (NYSE: S), T-Mobile US Inc. (NASDAQ: TMUS), Verizon Communications Inc. (NYSE: VZ) and AT&T play for position among customers in a saturated market. The iPhone 8 still gives them a chance to go after one another with a new chess piece.

  • [By Daniel B. Kline]

    While Sprint (NYSE:S) has an all-stock deal in place to merge with T-Mobile (NASDAQ:TMUS), there are significant doubts that federal regulators will approve it. If that happens, T-Mobile will go back to its fight against Verizon (NYSE:VZ) and AT&T (NYSE:T), with perhaps some added maverick credibility.

Top 10 Low Price Stocks To Buy For 2019: Bovie Medical Corporation(BVX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Ethan Ryder]

    TheStreet upgraded shares of Bovie Medical (NYSEAMERICAN:BVX) from a d rating to a c- rating in a research report report published on Monday morning.

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o

Top 10 Low Price Stocks To Buy For 2019: Gladstone Commercial Corporation(GOOD)

Advisors’ Opinion:

  • [By Max Byerly]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its genesis date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

  • [By Shane Hupp]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its launch date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

Top 10 Blue Chip Stocks To Invest In 2018

Shutterstock

Dont take any stated yields for granted these days! The financial news has been flooded with dividend cuts lately, with Teva Pharmaceutical (TEVA) and Mattel (MAT) taking the hatchet to their payouts, and telecom Windstream (WIN) dropping its dividend too.

Its dangerous to buy headline yields or even supposedly safe blue chips with more modest dividends without looking at the profits funding these payouts. Companies with high payout ratios (how much in earnings, funds from operations and other measures a company pays out in the form of dividends) are a twofold risk:

High payout ratios can lead to a slowing in dividend growth, which means your payout is increasingly likely to fall behind inflation.

Top 10 Blue Chip Stocks To Invest In 2018: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    T-Mobile’s (NASDAQ:TMUS) aggressive pursuit of growth over the past few years has already been paying off, but Verizon Communications'(NYSE:VZ)earnings report this morning showing that it lost retail customers for the first time represents an important inflection point in the U.S. wireless industry. While T-Mobile has been poaching customers from all other carriers for years, the dominant domestic wireless carrier has held up relatively well despite intensifying competition — until now.

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian spoke about unusually high options activity in Home Depot Inc (NYSE: HD) and T-Mobile US Inc (NASDAQ: TMUS).

  • [By The Ticker Tape]

    Analysts at Raymond James think smartphone sell-through weakened in the U.S. in the past quarter, which matches softer demand reported in recent earnings from Verizon Communications Inc. (NYSE: VZ), AT&T Inc. (NYSE: T) and T-Mobile US Inc (NASDAQ: TMUS). Later this year, the company is expected to launch a new version of its iPhone.  

  • [By Douglas A. McIntyre]

    One of the notable things about the mall is the number of troubled retailers it houses. Long term, this may be bad for the mall’s finances. Macy’s, Abercrombie & Fitch Co. (NYSE: ANF), GameStop Corp. (NYSE: GME) and Gap Inc. (NYSE: GPS) have locations. However, Mall of America has buttressed its tenant list with scores of restaurants and with retailers like Apple Inc. (NASDAQ: AAPL), Microsoft Corp. (NASDAQ: MSFT) and T-Mobile US Inc. (NASDAQ: TMUS), which have very well-financed parents.

Top 10 Blue Chip Stocks To Invest In 2018: MGM Resorts International(MGM)

Advisors’ Opinion:

  • [By Craig Jones]

    Jon Najarian noticed some call options activity in MGM Resorts International (NYSE: MGM). Traders were buying the September 32/37 call spread in the first half of the session on Thursday. Najarian likes the trade and he decided to initiate a long position in MGM Resorts.

  • [By Ben Levisohn]

    Wynn wasn’t the only Macau casino operator that took it on the chin today. Las Vegas Sands (LVS) tumbled 13% to $54.67, while Melco Crown Entertainment (MPEL) plunged 14% to $16.87, and MGM Resorts International (MGM) dropped 4.3% to $28.65.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Jon C. Ogg]

    MGM Resorts International (NYSE: MGM) is also a top pick for the first quarter, and Merrill Lynch’s price objective of $33.00 was versus a recent price of $28.50. The consensus analyst target price is a tad higher at $33.86.

  • [By Ben Levisohn]

    With companies like Under Armour (UAA), MGM Resorts International (MGM), andUnited Parcel Service (UPS) reporting tomorrow, we thought we’d get a jump start on the stocks moving after today’s close:

Top 10 Blue Chip Stocks To Invest In 2018: Knight Transportation, Inc.(KNX)

Advisors’ Opinion:

  • [By Rich Smith]

    Knight Transportation (NYSE:KNX) is merging with Swift Transportation (NYSE:SWFT) to build a $5 billion trucking behemoth — and Wall Street thinks that’s a good thing.

Top 10 Blue Chip Stocks To Invest In 2018: Kohl’s Corporation(KSS)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    One theme that’s become apparent is that consumers are betting that a Trump tax cut will lead to more money in their pockets. That’s good news for the so-called “trade-up” stocks like Nordstrom (JWN) and Kohl’s (KSS) .

  • [By Craig Jones]

    Jon Najarian noticed that options traders were buying out of the money puts in Kohl's Corporation (NYSE: KSS). The company is going to report earnings on August 10 and it seems that traders believe the stock is going to continue to trade lower.

  • [By WWW.THESTREET.COM]

    The Bad

    Bonds behaved poorly. The 10 year and long bond rose by between 3-4 basis points in yield. I bought a trading position in iShares Barclays 20+ Yr Treas.Bond ETF (TLT) in front of a possible yearend pension rebalance. Big pharma stinks up the joint, again. Spec biotech is weakening again (Portola Pharmaceuticals PTLA, ACADIA Pharmaceuticals ACAD, etc.) Retail cant get out of its way. I am long JC Penney (JCP) and have trading positions in Kohl’s (KSS) and Macy’s (M) . (Nike (NKE) , Nordstrom (JWN) , Lowe’s (LOW) are downside features).

    The Ugly

  • [By Ben Levisohn]

    By now, we all know retailers are facing a tough time. More and more, people are choosing to shop online, putting sales under pressure and leaving many with too many stores. Some department stores have begun to acknowledge the problems–but will they be able to adjust quickly enough in a rapidly changing landscape? Credit Suisse analyst Christian Bussand team believe this process is “well under way” but that didn’t stop them from downgrading Kohl’s (KSS) and J.C. Penney (JCP), even as they upgraded Nordstrom (JWN) and Burlington Stores(BURL). They explain why:

  • [By Ben Levisohn]

    Kohl’s (KSS) tumbled to the bottom of the S&P 500 today after offering earnings guidance that was well below analyst forecasts.

    Getty Images

    Kohl’sdropped 19% to $42.01 today, while the S&P 500 dipped 0.1% to 2,269.00.

    RBC’s Brian Tunick and Bilun Boyner worry that the bear case gas been revived:

    Kohl’s reported Holiday comps of -2%, below our model for -0.5%, as sales remained volatile through the quarter. Similar to early commentary by peers, stronger sales for Black Friday and the week before Christmas were offset by softness in early November and December. In line with Q3, the strongest categories were men’s, home, and footwear while accessories was most challenging.

    In addition to the sales downside,Kohl’s lowered its EPS guidance to $3.603.65 (from $3.804.00) to reflect lower than expected gross margins (we estimate were down 5060bps versus our prior model for up 40bp), which was mainly due to mix, timing of sales, and promotional environment as the company worked to exit the year with clean inventory positions (planning to end the year with inventories down mid-to-high SD)…

    AlthoughKohl’s still has a reasonable 1H’17 opportunity with easy gross margin compares, Under Armour (UA) launch, and potential for a new CFO, we believe disappointing Holiday sales and the guidance cut removed most of the market’s excitement around a return to momentum, reviving the secular bear case around department stores and Kohl’s. Maintaining Underperform and lowering price target to $42.

    Kohl’s market capitalization fell to $7.7 billion today from $9.2 billion yesterday. It reported net income of $673 million on sales of $19 billion in 2016.

Top 10 Blue Chip Stocks To Invest In 2018: Allegheny Technologies Incorporated(ATI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday morning, the basic materials shares climbed by 0.95 percent. Meanwhile, top gainers in the sector included Allegheny Technologies Incorporated (NYSE: ATI), up 5 percent, and Mechel PAO (ADR) (NYSE: MTL), up 5 percent.

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions. Major market benchmarks finished the day with gains of 0.5% to 1%, but some stocks did much better. Among the best performers on the day were Allegheny Technologies (NYSE:ATI), II-VI (NASDAQ:IIVI), and Beazer Homes (NYSE:BZH). Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Blue Chip Stocks To Invest In 2018: Renesola Ltd.(SOL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Wall Street expects ReneSola Ltd. (ADR) (NYSE: SOL) to report a quarterly loss at $0.04 per share on revenue of $256.05 million. ReneSola shares gained 2.50 percent to close at $1.23 on Friday.

  • [By Monica Gerson]

    ReneSola Ltd. (ADR) (NYSE: SOL) is estimated to report a quarterly loss at $0.04 per share on revenue of $256.05 million.

    America’s Car-Mart, Inc. (NASDAQ: CRMT) is projected to post its quarterly earnings at $0.58 per share on revenue of $149.13 million.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Monica Gerson]

    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 9.76 percent to $1.35 in pre-market trading. ReneSola reported Q1 earnings of $0.06 per share on revenue of $260.7 million.

Top 10 Blue Chip Stocks To Invest In 2018: Zillow Group, Inc.(Z)

Advisors’ Opinion:

  • [By Steve Symington]

    The stock market was mostly flat today ahead of a key House vote on the passage of the Republicans’ healthcare bill, which was delayed until Friday after GOP lawmakers failed to gather the necessary support. TheDow Jones Industrial Averagelost just 5 points, or 0.02%, while other broader market indexes saw similar small declines. But several individual stocks saw much more severe drops, including Zillow Group (NASDAQ:Z) (NASDAQ:ZG), Proofpoint (NASDAQ:PFPT), and Accenture (NYSE:ACN). Read on to see what drove these unusual moves.

  • [By Steve Symington]

    Shares of Zillow Group Inc. (NASDAQ:Z)(NASDAQ:ZG)climbed 13.8% in the month of April,according to data provided byS&P Global Market Intelligence, ahead of the online real estate specialist’s impending first-quarter 2017 report.

  • [By Nelson Hem]

    Also in this week’s Barron’s:

    A special report on strategic beta ETFs How to take advantage of underpriced stocks Who is in denial about the death of the personal computer market Finding the best value mutual funds Finding value in big stocks and emerging markets How mining companies are striving for sustainability Why Zillow Group, Inc.-Class C (NASDAQ: Z) could fall 25 percent Six unconventional yield plays for an uncertain market Why Alibaba Group Holding Ltd (NYSE: BABA) investors may lose in hot IPO

    Disclosure: At the time of this writing, the author had no position in the mentioned equities.

Top 10 Blue Chip Stocks To Invest In 2018: Catalyst Pharmaceuticals, Inc.(CPRX)

Advisors’ Opinion:

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

  • [By Lisa Levin]

    Shares of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) got a boost, shooting up 32 percent to $1.54 after the company reported positive data from investigator-sponsored trial of Firdapse.

Top 10 Blue Chip Stocks To Invest In 2018: Quality Systems, Inc.(QSII)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Elite Opportunity Pronewsletter suggested small cap health care technology stock Quality Systems, Inc (NASDAQ: QSII) as a short-term trading opportunity after popping sharply on news:

Top 10 Blue Chip Stocks To Invest In 2018: News Corporation(NWS)

Advisors’ Opinion:

  • [By Monica Gerson]

    News Corp (NASDAQ: NWS) reported a profit of $506 million, or $0.87 per share for the year ended June 30, versus a year-ago loss of $2.08 billion, or $3.58 per share. Its revenue rose 2.7% to $8.89 billion. However, analysts were expecting earnings of $0.57 per share on revenue of $8.96 billion. News Corp shares fell 1.28% to close at $16.91 on Friday.